• The next i-generation

    Discover the new random access device IDS i20 – designed with a focus on reliability, versatility and usability for the efficient, flexible and simple automation of chemiluminescence immunoassays (ChLIA).

    more
  • EUROMEDLAB 2025 in Brussels

    Visit us at EUROMEDLAB in Brussel, Belgium, from 18 to 22 May 2025, booth 318 in Hall 11.

    more
  • Hand in hand for powerful endocrinology

    EUROIMMUN and IDS combine quality and progress in a unique way, offering comprehensive panels of accurate and reliable chemiluminescence assays – backed up by extensive scientific studies – and maximum walk-away automation.

    Website
  • NEW: Anti-Measles Virus ELISA 2.0 (IgG)

    Detection of anti-measles virus antibodies now also possible using dried blood spots (DBS) - minimally invasive sampling and high sample stability.

    more
  • APOE genotyping in Alzheimer's disease

    In the therapy of Alzheimer’s disease with new active substances (e.g. lecanemab, donanemab), patients with two copies of the apolipoprotein E (APOE) allele ε4 have an increased risk of potentially life-threatening side effects. APOE genotyping with the EURORealTime APOE prior to therapy provides clarity.

    more
  • Our solutions for infection diagnostics in the world

    We develop and globally distribute complete diagnostic solutions that are tailored to your local needs.

    Website
What are you looking for?

News

News